Dren Bio
Dren Bio develops antibody therapies for cancer, autoimmune conditions and other serious diseases.
$350MPrivate financing
ParticipantActivity from announced rounds
Dren Bio develops antibody therapies for cancer, autoimmune conditions and other serious diseases.
Developing a new class of anti-IgE therapy to treat food allergy and other atopic conditions
Develops automated flight control systems for aircraft